RxDoctor Payments Data

James Mahalek, MD

Orthopaedic Surgery · Kearney, NENPI 1104873918

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.5%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Globus Medical at 44.9% of the total. Reporting peaked in 2019 at $3,324 and has fallen 87.1% since, to $429 in 2025.

$11,039in general payments, 2019–2025

Across 49 payments — averaging $225.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$5K
  • Abbott$3K
  • Corelink, LLC$3K
  • Johnson & Johnson$33
  • Linvatec Corporation$18

What the payments were for

  • Royalty or licence$4,95545%
  • Travel & lodging$5,13647%
  • Food & beverage$9489%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Globus Medical26$4,955
Abbott17$3,179
Corelink, LLC3$2,854
Johnson & Johnson2$33
Linvatec Corporation1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,039 in reported general payments places this provider in the 80th percentile of 155 orthopaedic surgery providers in Nebraska.

See all orthopaedic surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$117,777
Medicare patients
173
Services billed
693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$136
Tizanidine Hcl25$66

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Kearney

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →